Neurobo Pharmaceuticals Inc (NRBO) stock is lower by -96.92% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives NRBO stock a score of 7 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 1. NRBO's rank also includes a long-term technical score of 20. NRBO has an Overall Score of 7. Find out what this means to you and get the rest of the rankings on NRBO!